Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 367

1.

Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers.

Schink JC, Trosman JR, Weldon CB, Siziopikou KP, Tsongalis GJ, Rademaker AW, Patel JD, Benson AB 3rd, Perez EA, Gradishar WJ.

J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju256. doi: 10.1093/jnci/dju256. Print 2014 Oct.

PMID:
25217578
[PubMed - in process]
2.

Harmonization of the evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs-working group 2014.

Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehne FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S.

Ann Oncol. 2014 Sep 11. pii: mdu450. [Epub ahead of print] Review.

PMID:
25214542
[PubMed - as supplied by publisher]
3.

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.

Ingle JN, Kr K, Buzdar AU, Robson ME, Goetz MP, Desta Z, Barman P, Dudenkov TT, Northfelt DW, Perez EA, Flockhart DA, Williard CV, Wang L, Weinshilboum RM.

Steroids. 2014 Aug 24. pii: S0039-128X(14)00200-1. doi: 10.1016/j.steroids.2014.08.007. [Epub ahead of print]

PMID:
25163006
[PubMed - as supplied by publisher]
4.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.

de Azambuja E, Holmes AP, Piccart-Gebhart M, Holmes E, Di Cosimo S, Swaby RF, Untch M, Jackisch C, Lang I, Smith I, Boyle F, Xu B, Barrios CH, Perez EA, Azim HA Jr, Kim SB, Kuemmel S, Huang CS, Vuylsteke P, Hsieh RK, Gorbunova V, Eniu A, Dreosti L, Tavartkiladze N, Gelber RD, Eidtmann H, Baselga J.

Lancet Oncol. 2014 Sep;15(10):1137-46. doi: 10.1016/S1470-2045(14)70320-1. Epub 2014 Aug 14.

PMID:
25130998
[PubMed - in process]
5.

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

Schneider BP, Li L, Shen F, Miller KD, Radovich M, O'Neill A, Gray RJ, Lane D, Flockhart DA, Jiang G, Wang Z, Lai D, Koller D, Pratt JH, Dang CT, Northfelt D, Perez EA, Shenkier T, Cobleigh M, Smith ML, Railey E, Partridge A, Gralow J, Sparano J, Davidson NE, Foroud T, Sledge GW.

Br J Cancer. 2014 Sep 9;111(6):1241-8. doi: 10.1038/bjc.2014.430. Epub 2014 Aug 12.

PMID:
25117820
[PubMed - in process]
6.

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.

Cheng H, Ballman K, Vassilakopoulou M, Dueck AC, Reinholz MM, Tenner K, Gralow J, Hudis C, Davidson NE, Fountzilas G, McCullough AE, Chen B, Psyrri A, Rimm DL, Perez EA.

Br J Cancer. 2014 Sep 9;111(6):1065-71. doi: 10.1038/bjc.2014.442. Epub 2014 Aug 12.

PMID:
25117817
[PubMed - in process]
7.

Infant with bilateral pulmonary sequestrations with portal venous drainage excised by video-assisted thoracic surgery.

Parikh PP, Tashiro J, Chahwala V, Perez EA, Sola JE.

J Pediatr Surg. 2014 Aug;49(8):1332-4. doi: 10.1016/j.jpedsurg.2014.06.004. Epub 2014 Jul 10.

PMID:
25092101
[PubMed - in process]
8.

Trauma induced hypercoagulablity in pediatric patients.

Ryan ML, Van Haren RM, Thorson CM, Andrews DM, Perez EA, Neville HL, Sola JE, Proctor KG.

J Pediatr Surg. 2014 Aug;49(8):1295-9. doi: 10.1016/j.jpedsurg.2013.11.050. Epub 2013 Nov 16.

PMID:
25092093
[PubMed - in process]
9.

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199.

Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS.

J Clin Oncol. 2014 Jul 28. pii: JCO.2013.55.0491. [Epub ahead of print]

PMID:
25071121
[PubMed - as supplied by publisher]
10.

Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831.

Norton N, Olson RM, Pegram M, Tenner K, Ballman KV, Clynes R, Knutson KL, Perez EA.

Cancer Immunol Res. 2014 Jul 2. [Epub ahead of print]

PMID:
24989892
[PubMed - as supplied by publisher]
11.

Immunoscoring breast cancer: TILs remember what they target.

Curigliano G, Perez EA.

Ann Oncol. 2014 Aug;25(8):1455-6. doi: 10.1093/annonc/mdu227. Epub 2014 Jun 20. No abstract available.

PMID:
24950980
[PubMed - in process]
12.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Shulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R, Martino S, Shapiro CL, Schneider CJ, Kimmick G, Burstein HJ, Norton L, Muss H, Hudis CA, Winer EP.

J Clin Oncol. 2014 Aug 1;32(22):2311-7. doi: 10.1200/JCO.2013.53.7142. Epub 2014 Jun 16.

PMID:
24934787
[PubMed - in process]
13.

New developments in metastatic breast cancer: integrating recent data into clinical practice.

Perez EA, Rugo HS, Vahdat LT.

Clin Adv Hematol Oncol. 2013 Oct;11(10 Suppl 16):1-18; quiz 19.

PMID:
24892840
[PubMed - in process]
14.

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer.

Perez EA, Hurvitz SA, Amler LC, Mundt KE, Ng V, Guardino E, Gianni L.

Breast Cancer Res. 2014 May 23;16(3):R50. [Epub ahead of print]

PMID:
24887458
[PubMed - as supplied by publisher]
15.

A nationwide analysis of clinical outcomes among newborns with esophageal atresia and tracheoesophageal fistulas in the United States.

Wang B, Tashiro J, Allan BJ, Sola JE, Parikh PP, Hogan AR, Neville HL, Perez EA.

J Surg Res. 2014 Aug;190(2):604-12. doi: 10.1016/j.jss.2014.04.033. Epub 2014 Apr 28.

PMID:
24881472
[PubMed - indexed for MEDLINE]
16.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group.

N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1.

PMID:
24881463
[PubMed - indexed for MEDLINE]
17.

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU.

J Clin Oncol. 2014 Jul 1;32(19):2100-8. doi: 10.1200/JCO.2013.54.0955. Epub 2014 May 5. Review.

PMID:
24799487
[PubMed - indexed for MEDLINE]
18.

Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.

Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Gonzalez-Angulo AM, Krop I, Levinson J, Lin NU, Modi S, Patt DA, Perez EA, Perlmutter J, Ramakrishna N, Winer EP; American Society of Clinical Oncology.

J Clin Oncol. 2014 Jul 1;32(19):2078-99. doi: 10.1200/JCO.2013.54.0948. Epub 2014 May 5. Review.

PMID:
24799465
[PubMed - indexed for MEDLINE]
19.

New developments in metastatic breast cancer: general discussion.

Vahdat LT, Rugo HS, Perez EA.

Clin Adv Hematol Oncol. 2013 Oct;11(10 Suppl 16):16-7. No abstract available.

PMID:
24765684
[PubMed - in process]
20.

Practice-changing data in metastatic breast cancer.

Perez EA.

Clin Adv Hematol Oncol. 2013 Oct;11(10 Suppl 16):7-12. No abstract available.

PMID:
24637555
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk